Skip to main content
Erschienen in: Clinical and Experimental Medicine 3/2016

17.05.2015 | Original Article

Oxidative stress levels are correlated with P15 and P16 gene promoter methylation in myelodysplastic syndrome patients

verfasst von: Ana Cristina Gonçalves, Emília Cortesão, Barbara Oliveiros, Vera Alves, Ana Isabel Espadana, Luís Rito, Emília Magalhães, Sónia Pereira, Amélia Pereira, José Manuel Nascimento Costa, Luisa Mota-Vieira, Ana Bela Sarmento-Ribeiro

Erschienen in: Clinical and Experimental Medicine | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Oxidative stress and abnormal DNA methylation have been implicated in some types of cancer, namely in myelodysplastic syndromes (MDS). Since both mechanisms are observed in MDS patients, we analyzed the correlation of intracellular levels of peroxides, superoxide anion, and glutathione (GSH), as well as ratios of peroxides/GSH and superoxide/GSH, with the methylation status of P15 and P16 gene promoters in bone marrow leukocytes from MDS patients. Compared to controls, these patients had lower GSH content, higher peroxide levels, peroxides/GSH and superoxide/GSH ratios, as well as higher methylation frequency of P15 and P16 gene promoters. Moreover, patients with methylated P15 gene had higher oxidative stress levels than patients without methylation (peroxides: 460 ± 42 MIF vs 229 ± 25 MIF, p = 0.001; superoxide: 383 ± 48 MIF vs 243 ± 17 MIF, p = 0.022; peroxides/GSH: 2.50 ± 0.08 vs 1.04 ± 0.34, p < 0.001; superoxide/GSH: 1.76 ± 0.21 vs 1.31 ± 0.10, p = 0.007). Patients with methylated P16 and at least one methylated gene had higher peroxide levels as well as peroxides/GSH ratio than patients without methylation. Interestingly, oxidative stress levels allow the discrimination of patients without methylation from ones with methylated P15, methylated P16, or at least one methylated (P15 or P16) promoter. Taken together, these findings support the hypothesis that oxidative stress is correlated with P15 and P16 hypermethylation.
Literatur
1.
Zurück zum Zitat Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.CrossRefPubMed Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.CrossRefPubMed
2.
Zurück zum Zitat Hole PS, Darley RL, Tonks A. Do reactive oxygen species play a role in myeloid leukemias? Blood. 2011;117:5816–26.CrossRefPubMed Hole PS, Darley RL, Tonks A. Do reactive oxygen species play a role in myeloid leukemias? Blood. 2011;117:5816–26.CrossRefPubMed
3.
Zurück zum Zitat Farquhar MJ, Bowen DT. Oxidative stress and the myelodysplastic syndromes. Int J Hematol. 2003;77:342–50.CrossRefPubMed Farquhar MJ, Bowen DT. Oxidative stress and the myelodysplastic syndromes. Int J Hematol. 2003;77:342–50.CrossRefPubMed
4.
Zurück zum Zitat Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol. 2010;38:96–109.CrossRefPubMed Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol. 2010;38:96–109.CrossRefPubMed
8.
Zurück zum Zitat Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004;44:239–67.CrossRefPubMed Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004;44:239–67.CrossRefPubMed
11.
Zurück zum Zitat Galm O, Herman JG, Baylin SB. The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev. 2006;20:1–13.CrossRefPubMed Galm O, Herman JG, Baylin SB. The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev. 2006;20:1–13.CrossRefPubMed
13.
Zurück zum Zitat Karlic H, Herrmann H, Varga F, et al. The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia. Crit Rev Oncol Hematol. 2014;90:1–16.CrossRefPubMed Karlic H, Herrmann H, Varga F, et al. The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia. Crit Rev Oncol Hematol. 2014;90:1–16.CrossRefPubMed
14.
Zurück zum Zitat Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive oxygen species (ROS) induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res. 2011;711:167–73.CrossRefPubMed Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive oxygen species (ROS) induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res. 2011;711:167–73.CrossRefPubMed
16.
Zurück zum Zitat Cerda S, Weitzman SA. Influence of oxygen radical injury on DNA methylation. Mutat Res. 1997;386:141–52.CrossRefPubMed Cerda S, Weitzman SA. Influence of oxygen radical injury on DNA methylation. Mutat Res. 1997;386:141–52.CrossRefPubMed
17.
Zurück zum Zitat Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett. 2008;266:6–11.CrossRefPubMed Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett. 2008;266:6–11.CrossRefPubMed
19.
20.
Zurück zum Zitat Ghoti H, Amer J, Winder A, Rachmilewitz E, Fibach E. Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome. Eur J Haematol. 2007;79:463–7.CrossRefPubMed Ghoti H, Amer J, Winder A, Rachmilewitz E, Fibach E. Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome. Eur J Haematol. 2007;79:463–7.CrossRefPubMed
21.
Zurück zum Zitat Novotna B, Bagryantseva Y, Siskova M, Neuwirtova R. Oxidative DNA damage in bone marrow cells of patients with low risk myelodysplastic syndrome. Leuk Res. 2009;33:340–3.CrossRefPubMed Novotna B, Bagryantseva Y, Siskova M, Neuwirtova R. Oxidative DNA damage in bone marrow cells of patients with low risk myelodysplastic syndrome. Leuk Res. 2009;33:340–3.CrossRefPubMed
22.
Zurück zum Zitat Brunning R, Orazi A, Germing U, et al. Myelodysplastic syndromes/neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 88–103. Brunning R, Orazi A, Germing U, et al. Myelodysplastic syndromes/neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 88–103.
23.
Zurück zum Zitat Almeida S, Sarmento-Ribeiro AB, Januário C, Rego AC, Oliveira CR. Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington’s disease patients. Biochem Biophys Res Commun. 2008;374:599–603.CrossRefPubMed Almeida S, Sarmento-Ribeiro AB, Januário C, Rego AC, Oliveira CR. Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington’s disease patients. Biochem Biophys Res Commun. 2008;374:599–603.CrossRefPubMed
24.
Zurück zum Zitat Zielonka J, Vasquez Vivar J, Kalyanaraman B. Detection of 2 hydroxyethidium in cellular systems: a unique marker product of superoxide and hydroethidine. Nat Protoc. 2008;3:8–21.CrossRefPubMed Zielonka J, Vasquez Vivar J, Kalyanaraman B. Detection of 2 hydroxyethidium in cellular systems: a unique marker product of superoxide and hydroethidine. Nat Protoc. 2008;3:8–21.CrossRefPubMed
25.
Zurück zum Zitat O’Connor JE, Kimler BF, Morgan MC, Tempas KJ. A flow cytometric assay for intracellular nonprotein thiols using mercury orange. Cytometry. 1988;9:529–32.CrossRefPubMed O’Connor JE, Kimler BF, Morgan MC, Tempas KJ. A flow cytometric assay for intracellular nonprotein thiols using mercury orange. Cytometry. 1988;9:529–32.CrossRefPubMed
26.
Zurück zum Zitat Yeh KT, Chang JG, Lin TH, et al. Epigenetic changes of tumor suppressor genes, P15, P16, VHL and P53 in oral cancer. Oncol Rep. 2003;10:659–63.PubMed Yeh KT, Chang JG, Lin TH, et al. Epigenetic changes of tumor suppressor genes, P15, P16, VHL and P53 in oral cancer. Oncol Rep. 2003;10:659–63.PubMed
27.
Zurück zum Zitat Nishida N, Arizumi T, Takita M, et al. Reactive oxygen species induce epigenetic instability through the formation of 8 hydroxydeoxyguanosine in human hepatocarcinogenesis. Dig Dis. 2013;31:459–66.CrossRefPubMed Nishida N, Arizumi T, Takita M, et al. Reactive oxygen species induce epigenetic instability through the formation of 8 hydroxydeoxyguanosine in human hepatocarcinogenesis. Dig Dis. 2013;31:459–66.CrossRefPubMed
28.
Zurück zum Zitat Patchsung M, Boonla C, Amnattrakul P, Dissayabutra T, Mutirangura A, Tosukhowong P. Long interspersed nuclear element 1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential. PLoS ONE. 2012;7:e37009.CrossRefPubMedPubMedCentral Patchsung M, Boonla C, Amnattrakul P, Dissayabutra T, Mutirangura A, Tosukhowong P. Long interspersed nuclear element 1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential. PLoS ONE. 2012;7:e37009.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Lim SO, Gu JM, Kim MS, et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E cadherin promoter. Gastroenterology. 2008;135:2128–40.CrossRefPubMed Lim SO, Gu JM, Kim MS, et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E cadherin promoter. Gastroenterology. 2008;135:2128–40.CrossRefPubMed
30.
Zurück zum Zitat Min JY, Lim SO, Jung G. Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter. FEBS Lett. 2010;584:2427–32.CrossRefPubMed Min JY, Lim SO, Jung G. Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter. FEBS Lett. 2010;584:2427–32.CrossRefPubMed
31.
Zurück zum Zitat Quan X, Lim SO, Jung G. Reactive oxygen species downregulate catalase expression via methylation of a CpG Island in the Oct 1 promoter. FEBS Lett. 2011;585:3436–41.CrossRefPubMed Quan X, Lim SO, Jung G. Reactive oxygen species downregulate catalase expression via methylation of a CpG Island in the Oct 1 promoter. FEBS Lett. 2011;585:3436–41.CrossRefPubMed
32.
Zurück zum Zitat Wongpaiboonwattana W, Tosukhowong P, Dissayabutra T, Mutirangura A, Boonla C. Oxidative stress induces hypomethylation of LINE 1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line. Asian Pacific J Cancer Prev. 2013;14:3773–8.CrossRef Wongpaiboonwattana W, Tosukhowong P, Dissayabutra T, Mutirangura A, Boonla C. Oxidative stress induces hypomethylation of LINE 1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line. Asian Pacific J Cancer Prev. 2013;14:3773–8.CrossRef
33.
Zurück zum Zitat Solomon PR, Munirajan AK, Tsuchida N, et al. Promoter hypermethylation analysis in myelodysplastic syndromes: diagnostic & prognostic implication. Indian J Med Res. 2008;127:52–7.PubMed Solomon PR, Munirajan AK, Tsuchida N, et al. Promoter hypermethylation analysis in myelodysplastic syndromes: diagnostic & prognostic implication. Indian J Med Res. 2008;127:52–7.PubMed
34.
Zurück zum Zitat Claus R, Lübbert M. Epigenetic targets in hematopoietic malignancies. Oncogene. 2003;22:6489–96.CrossRefPubMed Claus R, Lübbert M. Epigenetic targets in hematopoietic malignancies. Oncogene. 2003;22:6489–96.CrossRefPubMed
35.
Zurück zum Zitat Quesnel B, Guillerm G, Vereecque R, et al. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood. 1998;91:2985–90.PubMed Quesnel B, Guillerm G, Vereecque R, et al. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood. 1998;91:2985–90.PubMed
36.
Zurück zum Zitat Tien HF, Tang JL, Tsay W, et al. Methylation of the p15INK4B gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. Br J Haematol. 2011;112:148–54.CrossRef Tien HF, Tang JL, Tsay W, et al. Methylation of the p15INK4B gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. Br J Haematol. 2011;112:148–54.CrossRef
37.
Zurück zum Zitat Aggerholm A, Holm MS, Guldberg P, Olesen LH, Hokland P. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early stage patients. Eur J Haematol. 2006;76:23–32.CrossRefPubMed Aggerholm A, Holm MS, Guldberg P, Olesen LH, Hokland P. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early stage patients. Eur J Haematol. 2006;76:23–32.CrossRefPubMed
38.
Zurück zum Zitat Saigo K, Takenokuchi M, Hiramatsu Y, et al. Oxidative stress levels in myelodysplastic syndrome patients: their relationship to serum ferritin and haemoglobin values. J Int Med Res. 2011;39:1941–5.CrossRefPubMed Saigo K, Takenokuchi M, Hiramatsu Y, et al. Oxidative stress levels in myelodysplastic syndrome patients: their relationship to serum ferritin and haemoglobin values. J Int Med Res. 2011;39:1941–5.CrossRefPubMed
39.
Zurück zum Zitat Peddie CM, Wolf CR, McLellan LI, Collins AR, Bowen DT. Oxidative DNA damage in CD34 + myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor alpha concentration. Br J Haematol. 1997;99:625–31.CrossRefPubMed Peddie CM, Wolf CR, McLellan LI, Collins AR, Bowen DT. Oxidative DNA damage in CD34 + myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor alpha concentration. Br J Haematol. 1997;99:625–31.CrossRefPubMed
40.
Zurück zum Zitat Honda M, Yamada Y, Tomonaga M, Ichinose H, Kamihira S. Correlation of urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study. Leuk Res. 2000;24:461–8.CrossRefPubMed Honda M, Yamada Y, Tomonaga M, Ichinose H, Kamihira S. Correlation of urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study. Leuk Res. 2000;24:461–8.CrossRefPubMed
41.
Zurück zum Zitat Soberanes S, Gonzalez A, Urich D, et al. Particulate matter air pollution induces hypermethylation of the p16 promoter via a mitochondrial ROS JNK DNMT1 pathway. Sci Rep. 2012;2:275.CrossRefPubMedPubMedCentral Soberanes S, Gonzalez A, Urich D, et al. Particulate matter air pollution induces hypermethylation of the p16 promoter via a mitochondrial ROS JNK DNMT1 pathway. Sci Rep. 2012;2:275.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Gonçalves AC, Alves R, Pires A, Jorge J, Mota-Vieira L, Nascimento-Costa JM, Sarmento-Ribeiro AB (2015) Chronic exposure to oxidative stress inducers influence methylation status in normal and neoplastic hematological cells. Rev Port Pneumol 21 (Esp Cong 1):18 Gonçalves AC, Alves R, Pires A, Jorge J, Mota-Vieira L, Nascimento-Costa JM, Sarmento-Ribeiro AB (2015) Chronic exposure to oxidative stress inducers influence methylation status in normal and neoplastic hematological cells. Rev Port Pneumol 21 (Esp Cong 1):18
43.
Zurück zum Zitat O’Hagan HM, Wang W, Sen S, et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG islands. Cancer Cell. 2011;20:606–19.CrossRefPubMedPubMedCentral O’Hagan HM, Wang W, Sen S, et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG islands. Cancer Cell. 2011;20:606–19.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Afanas’ev I. New nucleophilic mechanisms of ROS dependent epigenetic modifications: comparison of aging and cancer. Aging Dis. 2014;5:52–62.CrossRefPubMed Afanas’ev I. New nucleophilic mechanisms of ROS dependent epigenetic modifications: comparison of aging and cancer. Aging Dis. 2014;5:52–62.CrossRefPubMed
45.
Zurück zum Zitat Rang FJ, Boonstra J. Causes and consequences of age related changes in DNA methylation: a role for ROS? Biology (Basel). 2014;3:403–25. Rang FJ, Boonstra J. Causes and consequences of age related changes in DNA methylation: a role for ROS? Biology (Basel). 2014;3:403–25.
46.
Zurück zum Zitat Jankowska AM, Gondek LP, Szpurka H, Nearman ZP, Tiu RV, Maciejewski JP. Base excision repair dysfunction in a subgroup of patients with myelodysplastic syndrome. Leukemia. 2008;22:551–8.CrossRefPubMed Jankowska AM, Gondek LP, Szpurka H, Nearman ZP, Tiu RV, Maciejewski JP. Base excision repair dysfunction in a subgroup of patients with myelodysplastic syndrome. Leukemia. 2008;22:551–8.CrossRefPubMed
47.
Zurück zum Zitat Fenaux P, Rose C. Impact of iron overload in myelodysplastic syndromes. Blood Rev. 2009;23:S15–9.CrossRefPubMed Fenaux P, Rose C. Impact of iron overload in myelodysplastic syndromes. Blood Rev. 2009;23:S15–9.CrossRefPubMed
48.
Zurück zum Zitat Steensma DP, Gattermann N. When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes? Best Pract Res Clin Haematol. 2013;26:431–44.CrossRefPubMed Steensma DP, Gattermann N. When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes? Best Pract Res Clin Haematol. 2013;26:431–44.CrossRefPubMed
49.
Zurück zum Zitat Kikuchi S, Kobune M, Iyama S, et al. Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome. Int J Hematol. 2012;95:527–34.CrossRefPubMed Kikuchi S, Kobune M, Iyama S, et al. Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome. Int J Hematol. 2012;95:527–34.CrossRefPubMed
50.
Zurück zum Zitat Bystrom LM, Rivella S. Cancer cells with irons in the fire. Free Radic Biol Med. 2015;79C:337–42.CrossRef Bystrom LM, Rivella S. Cancer cells with irons in the fire. Free Radic Biol Med. 2015;79C:337–42.CrossRef
51.
Zurück zum Zitat Ghoti H, Fibach E, Merkel D, et al. Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes. Haematologica. 2010;95:1433–4.CrossRefPubMedPubMedCentral Ghoti H, Fibach E, Merkel D, et al. Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes. Haematologica. 2010;95:1433–4.CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Mufti GJ. Pathobiology, classification, and diagnosis of myelodysplastic syndrome. Best Pract Res Clin Haematol. 2004;17:543–57.CrossRefPubMed Mufti GJ. Pathobiology, classification, and diagnosis of myelodysplastic syndrome. Best Pract Res Clin Haematol. 2004;17:543–57.CrossRefPubMed
Metadaten
Titel
Oxidative stress levels are correlated with P15 and P16 gene promoter methylation in myelodysplastic syndrome patients
verfasst von
Ana Cristina Gonçalves
Emília Cortesão
Barbara Oliveiros
Vera Alves
Ana Isabel Espadana
Luís Rito
Emília Magalhães
Sónia Pereira
Amélia Pereira
José Manuel Nascimento Costa
Luisa Mota-Vieira
Ana Bela Sarmento-Ribeiro
Publikationsdatum
17.05.2015
Verlag
Springer International Publishing
Erschienen in
Clinical and Experimental Medicine / Ausgabe 3/2016
Print ISSN: 1591-8890
Elektronische ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-015-0357-2

Weitere Artikel der Ausgabe 3/2016

Clinical and Experimental Medicine 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.